New patent for Gilead Sciences drug SUNLENCA
Annual Drug Patent Expirations for SUNLENCA Sunlenca is a drug marketed by Gilead Sciences Inc and is included in two […]
Patent Added
New patent for Esperion Theraps drug NEXLIZET
Annual Drug Patent Expirations for NEXLIZET Nexlizet is a drug marketed by Esperion Theraps Inc and is included in one
New patent for Neos Theraps drug ADZENYS XR-ODT
Annual Drug Patent Expirations for ADZENYS+XR-ODT Adzenys Xr-odt is a drug marketed by Neos Theraps and is included in one
New patent for Esperion Theraps drug NEXLETOL
Annual Drug Patent Expirations for NEXLETOL Nexletol is a drug marketed by Esperion Theraps Inc and is included in one
New patent for Genentech Inc drug EVRYSDI
Annual Drug Patent Expirations for EVRYSDI Evrysdi is a drug marketed by Genentech Inc and is included in one NDA.
New patent for Tolmar drug ELIGARD KIT
Annual Drug Patent Expirations for ELIGARD+KIT Eligard Kit is a drug marketed by Tolmar and is included in four NDAs.
New patent for Gilead Sciences drug VEMLIDY
Annual Drug Patent Expirations for VEMLIDY Vemlidy is a drug marketed by Gilead Sciences Inc and is included in one
New patent for Aveo Pharms drug FOTIVDA
Annual Drug Patent Expirations for FOTIVDA Fotivda is a drug marketed by Aveo Pharms and is included in one NDA.
New patent for Tolmar drug FENSOLVI KIT
Annual Drug Patent Expirations for FENSOLVI+KIT Fensolvi Kit is a drug marketed by Tolmar and is included in one NDA.
